placebo + tetanus-diphtheria-acellular pertussis vaccine + human papillomavirus vaccine

This is not a commercial combination product but refers to the co-administration of tetanus-diphtheria-acellular pertussis (Tdap) vaccine and human papillomavirus (HPV) vaccine, sometimes with placebo in clinical trial settings. The CDC promotes a "bundling approach" for adolescent vaccines, where Tdap and HPV vaccines are administered during the same clinical visit but at separate injection sites. Studies have shown that adolescents who receive their first HPV vaccine bundled with the Tdap vaccine are 45% more likely to complete the HPV vaccine series compared to those who receive it alone.

Other names

Tdap-HPV vaccination bundling